(Q37156565)

18 August 2017

1 reference

title

Clinical target promiscuity: lessons from ras molecular trials (English)

1 reference

18 August 2017

3

Stephen M Hahn

1 reference

18 August 2017

Ramesh Rengan

1

1 reference

PubMed ID

18461427

18 August 2017

Keith A Cengel

series ordinal

2

1 reference

18 August 2017

1 September 2008

1 reference

Cancer and Metastasis Reviews

18 August 2017

1 reference

18 August 2017

27

1 reference

18 August 2017

403-414

1 reference

18 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s10555-008-9133-z

18 August 2017

0 references

cites work

Radiation sensitization of human cancer cells in vivo by inhibiting the activity of PI3K using LY294002.

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9133-Z

Phase I trial of tipifarnib (R115777) concurrent with radiotherapy in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9133-Z

DNA supercoiling changes and nuclear matrix-associated proteins: possible role in oncogene-mediated radioresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9133-Z

Radiosensitizing effects of the prenyltransferase inhibitor AZD3409 against RAS mutated cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10555-008-9133-Z

10.1007/S10555-008-9133-Z

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18461427